Clinical Trials in Austin

Showing 11181-11200 of 13,060 trials

An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia

NCT00524043

The purpose of this study is to assess the efficacy and safety of 1.5 mg/day dose of paliperidone Extended Release (ER) as compared with placebo when used to treat patients with schizophrenia.

Schizophrenia

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.201 participantsStarted Sep 2007

Cerritos, California, United States • Torrance, California, United States • Washington D.C., District of Columbia, United States +17 more locations

WITHDRAWNPhase 3< 1 mile

An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men

NCT02082197

This is an open-study with a 26 week open label treatment period followed by an optional 26 week open label extension. The total treatment period will be 52 weeks.

HypogonadismTestosterone Deficiency

AbbVieStarted Mar 2014

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Mesa, Arizona, United States +39 more locations

An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia

An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men

Find Trials by Condition in Austin

Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6

VA111913 Dysmenorrhoea Efficacy and Safety Proof of Concept

Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis

Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

A Trial of Degarelix in Patients With Prostate Cancer

Markers and Mechanisms of Vascular Disease in Type II Diabetes

Fatty Acid Binding Protein 2 (FABP2) Ancillary Proposal

Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy

Open-label Extension Study of Pramipexole in the Treatment of Children and Adolescents With Tourette Syndrome

Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old

Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease

Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)

Trial Evaluating the Safety and Effectiveness of NUBAC™ Disc Arthroplasty

Growth and Tolerance of Infants Fed Infant Formulas

Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer

Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique